Naiyer Rizvi - 01 Jun 2021 Form 3 Insider Report for Gritstone bio, Inc.

Role
Director
Signature
/s/ Rahsaan Thompson, Attorney-in-Fact for Naiyer Rizvi
Issuer symbol
N/A
Transactions as of
01 Jun 2021
Net transactions value
$0
Form type
3
Filing time
19 Nov 2021, 15:17:39 UTC
Next filing
19 Nov 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding GRTS Stock Option (Right to Buy) 01 Jun 2021 Common Stock 4,347 $0.7590 Direct F1
holding GRTS Stock Option (Right to Buy) 01 Jun 2021 Common Stock 10,000 $12.02 Direct F2
holding GRTS Stock Option (Right to Buy) 01 Jun 2021 Common Stock 7,500 $8.91 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully exercisable.
F2 Shares subject to the stock option vest and become exercisable on a monthly basis in equal monthly installments over a 36 month period commencing on March 1, 2019 (the "Vesting Commencement Date"), so that all shares subject to the stock option will become fully vested and exercisable on the third anniversary of the Vesting Commencement Date, subject to the Reporting Person remaining a service provider through each monthly anniversary of the grant date.
F3 Shares subject to the stock option vest and become exercisable on a monthly basis in equal monthly installments over a 36 month period commencing on March 1, 2020 (the "Vesting Commencement Date"), so that all shares subject to the stock option will become fully vested and exercisable on the third anniversary of the Vesting Commencement Date, subject to the Reporting Person remaining a service provider through each monthly anniversary of the grant date.